Thermo Fisher Scientific outlines new business segments with acquisition of Life Technologies.

Neolpharma opens its new Development and Innovation Center (CEDIPROF) for pharmaceutical products in Puerto Rico.

Edison and DSP partner to develop drugs targeting cellular energy metabolism.

Last year, the Turkish Government unveiled plans to position the country in the top 10 most-preferred locations for R&D investment in the pharmaceutical sector by 2023. This article provides an overview of the incentives introduced under the Technopolis Law and the R&D Act.

PDA works with FDA to create pharmaceutical quality metrics.

ISPE and PDA take on the challenge of recommending quality metrics.

Non-compliance issues show that users find dealing with computer systems challenging.

PharmaCell enters an agreement purchase TiGenix therapy production facility.

BASF receives EXCiPACT Certification for the group of polyvinylpyrrolidone polymers, produced in Germany.

Solvias appoints Karen Huebscher as its new CEO.

I Holland announces service that predicts solutions for tablet sticking problems.

Jeff Yuen had been appointed executive vice-president, global quality for combined companies.

Regis Technologies passes a recent FDA audit with no Form 483 observations.

Optima pharma GmbH appoints Stephan Reuter as its new CEO.

Eurofins MWG Operon expands its exome sequencing services with the Ion Proton Next Generation Sequencer.

Avantor Performance Materials adds VWR International locations to its certified excipient distributor program.

AstraZeneca and Bristol-Myers Squibb Diabetes Alliance provides a $5 million grant to the American Diabetes Association.

International Society for Pharmaceutical Engineering will continue strategic plan initiated by Nancy Berg; search begins for replacement.

Teva reports FDA approval for three-times-a-week Copaxone 40 mg/mL.

Covance appoints Barry J. Goldstein as its new vice-president of Clinical Development Services and Global Therapeutic Area Head.

SGS to offer program-based stability testing services for biopharmaceuticals from Wokingham, UK facility.

EMA's guidance focuses on the use of pharmacogenomics to improve drug safety monitoring.

NCI launches trial to assess the utility of genetic sequencing to improve patient outcomes.

Novozymes Biopharma has released new study data on extending the serum half-life of albumin in vivo.

The Committee for Medicinal Products for Human Use (CHMP) held a meeting on Jan. 20-23, 2014.

Products enable testing in accordance with methods described in new USP monograph.

FDA adds Ranbaxy's Toansa, India facility to existing consent decree, prohibiting distribution of APIs from that location

Competition seeks to encourage academic research and accelerate drug delivery applications.